IBD is characterized by chronic inflammation due to the release of inflammatory markers such as interleukin (IL-1β), IL-6 and tumor necrosis factor-alpha (TNF-α), mucosal injury, and immunological dysregulation, all of which cause debilitating symptoms and systemic effects [10] often associated with gut dysbiosis. This evidence concerns the gene TNF and inflammatory bowel disease.